147 related articles for article (PubMed ID: 11517005)
1. Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency.
Herschbach P; Henrich G; Strasburger CJ; Feldmeier H; Marín F; Attanasio AM; Blum WF
Eur J Endocrinol; 2001 Sep; 145(3):255-65. PubMed ID: 11517005
[TBL] [Abstract][Full Text] [Related]
2. [The quality-of-life questionnaire QLS-H: validation of the French language version of the questionnaire in patients with growth hormone deficiency and collection of reference data in the general population].
Rosilio M; Berthezène F; Blum WF; Shavrikova EP; Herschbach P; Henrich G
Ann Endocrinol (Paris); 2004 Oct; 65(5):439-50. PubMed ID: 15550886
[TBL] [Abstract][Full Text] [Related]
3. Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H).
Rosilio M; Blum WF; Edwards DJ; Shavrikova EP; Valle D; Lamberts SW; Erfurth EM; Webb SM; Ross RJ; Chihara K; Henrich G; Herschbach P; Attanasio AF
J Clin Endocrinol Metab; 2004 Apr; 89(4):1684-93. PubMed ID: 15070931
[TBL] [Abstract][Full Text] [Related]
4. Psychometric properties of two measures of psychological well-being in adult growth hormone deficiency.
McMillan CV; Bradley C; Gibney J; Russell-Jones DL; Sönksen PH
Health Qual Life Outcomes; 2006 Mar; 4():16. PubMed ID: 16553952
[TBL] [Abstract][Full Text] [Related]
5. Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module.
Blum WF; Shavrikova EP; Edwards DJ; Rosilio M; Hartman ML; Marín F; Valle D; van der Lely AJ; Attanasio AF; Strasburger CJ; Henrich G; Herschbach P
J Clin Endocrinol Metab; 2003 Sep; 88(9):4158-67. PubMed ID: 12970281
[TBL] [Abstract][Full Text] [Related]
6. Influences on quality of life in GH deficient adults and their effect on response to treatment.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
[TBL] [Abstract][Full Text] [Related]
7. The Polish version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) - four-stage translation and validation.
Karbownik-Lewińska M; Lewiński A; McKenna S; Kokoszko A; Mucha S; Komorowski J; Krzyzanowska-Swiniarska B; Gryczyńska M; Sowiński J; Junik R; Meads D; Kołtowska-Häggström M
Endokrynol Pol; 2008; 59(5):374-84. PubMed ID: 18979446
[TBL] [Abstract][Full Text] [Related]
8. Measurements of quality of life in patients with growth hormone deficiency.
Webb SM
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
[TBL] [Abstract][Full Text] [Related]
9. Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency.
McMillan CV; Bradley C; Gibney J; Healy ML; Russell-Jones DL; Sönksen PH
Clin Endocrinol (Oxf); 2003 Oct; 59(4):467-75. PubMed ID: 14510909
[TBL] [Abstract][Full Text] [Related]
10. Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study.
Mo D; Blum WF; Rosilio M; Webb SM; Qi R; Strasburger CJ
J Clin Endocrinol Metab; 2014 Dec; 99(12):4581-8. PubMed ID: 25233155
[TBL] [Abstract][Full Text] [Related]
11. Preliminary development of the new individualized HDQoL questionnaire measuring quality of life in adult hypopituitarism.
McMillan CV; Bradley C; Gibney J; Russell-Jones DL; Sönksen PH
J Eval Clin Pract; 2006 Oct; 12(5):501-14. PubMed ID: 16987112
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) enhances anaerobic capacity: impact on physical function and quality of life in adults with GH deficiency.
Chikani V; Cuneo RC; Hickman I; Ho KK
Clin Endocrinol (Oxf); 2016 Oct; 85(4):660-8. PubMed ID: 27346880
[TBL] [Abstract][Full Text] [Related]
13. IGF-I bioactivity might reflect different aspects of quality of life than total IGF-I in GH-deficient patients during GH treatment.
Varewijck AJ; Lamberts SW; Neggers SJ; Hofland LJ; Janssen JA
J Clin Endocrinol Metab; 2013 Feb; 98(2):761-8. PubMed ID: 23295465
[TBL] [Abstract][Full Text] [Related]
14. Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults.
Turner-Bowker DM; Yaworsky A; Palladino A; Lamoureux RE; Kelly M; Love E; Pleil AM; Shields A; Loftus J
Patient; 2020 Jun; 13(3):289-306. PubMed ID: 31956960
[TBL] [Abstract][Full Text] [Related]
15. Preliminary development of a new individualised questionnaire measuring quality of life in older men with age-related hormonal decline: the A-RHDQoL.
McMillan CV; Bradley C; Giannoulis M; Martin F; Sönksen PH
Health Qual Life Outcomes; 2003 Oct; 1():51. PubMed ID: 14613571
[TBL] [Abstract][Full Text] [Related]
16. The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency.
Wallymahmed ME; Baker GA; Humphris G; Dewey M; MacFarlane IA
Clin Endocrinol (Oxf); 1996 Apr; 44(4):403-11. PubMed ID: 8706306
[TBL] [Abstract][Full Text] [Related]
17. A novel quality of life instrument for deep brain stimulation in movement disorders.
Kuehler A; Henrich G; Schroeder U; Conrad B; Herschbach P; Ceballos-Baumann A
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1023-30. PubMed ID: 12876228
[TBL] [Abstract][Full Text] [Related]
18. Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.
Malik IA; Foy P; Wallymahmed M; Wilding JP; MacFarlane IA
Clin Endocrinol (Oxf); 2003 Jul; 59(1):75-81. PubMed ID: 12807507
[TBL] [Abstract][Full Text] [Related]
19. The "quality of life-assessment of growth hormone deficiency in adults" questionnaire: can it be used to assess quality of life in hypopituitarism?
Barkan AL
J Clin Endocrinol Metab; 2001 May; 86(5):1905-7. PubMed ID: 11344182
[TBL] [Abstract][Full Text] [Related]
20. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults.
Gilchrist FJ; Murray RD; Shalet SM
Clin Endocrinol (Oxf); 2002 Sep; 57(3):363-70. PubMed ID: 12201829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
